Skip to content

BioMarin Pharmaceuticals BMRN Product One — Accounts Receivable Net Current

Discontinued — last reported Q4 '17

Similar metrics at other companies

MKS Instruments logo
MKSIOperating Segments — Accounts Receivable Net Current
$341.72M+27.9%
Logitech International logo
LOGICustomer Programs — Accounts Receivable Net Current
$76.7M
News Corporation logo
NWSAFinancial Service — Accounts Receivable Net Noncurrent
$121M
Molina Healthcare logo
MOHAll Other Segments — Accounts Receivable Net
$40M
Aptiv logo
APTVReportable Legal Entities — Accounts Receivable Net Current
$2.6B-16.9%
Popular logo
BPOPAccounts Receivable

Other financials

Income statement

See full
Revenue$766.2M+2.8%
Gross profit$571.2M-3.8%
Operating income$129.6M-42.1%
Net income$105.5M-43.2%
EPS (diluted)$0.54-43.2%

Balance sheet

See full
Cash & equivalents$3.1B+193%
Total debt$1.4B+138%
Total equity$6.2B+7.2%
Total assets$8.6B+20.2%

Cash flow

See full
Operating cash flow$220.7M+26.5%
CapEx$20.9M+24.8%
Free cash flow$199.7M+26.7%

Valuation

See full
Market cap$10.57B-19.4%
Enterprise value$8.93B-29.3%
P/E21.1×-22.7×
P/S3.3×-1.2×

Profitability

See full
Gross margin76.5%-2.9pp
Operating margin19.9%+7.2pp
Net margin16.8%+5.1pp
FCF margin23.7%+2.5pp

Returns & leverage

See full
Return on equity9.1%+2.8pp
Debt / equity0.2×+0.1×
Current ratio5.8×+0.3×

Where this comes from

Reported directly by BioMarin Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:AccountsReceivableNetCurrent.

The official record: BioMarin Pharmaceuticals’s 10-K, filed February 28, 2019, on SEC EDGAR. View the filing →

Questions, answered.

What does product one — accounts receivable net current mean?
The amount of money customers owe the business segment for products already delivered.
How do you interpret product one — accounts receivable net current?
An increase may indicate rising sales or potential collection delays, while a decrease suggests faster cash conversion.
How does product one — accounts receivable net current compare across companies?
Similar to trade receivables in other pharmaceutical segments, typically benchmarked against days sales outstanding (DSO).